Editorial: Unlocking the potential of cell therapy: exploring cell types, induction methods, and culture techniques.
作者信息
Selvarajan Viknesvaran, Gan Samuel Ken-En, Ng Yuen Ling
机构信息
Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Antibody & Product Development (APD) Lab, Wenzhou-Kean University, Wenzhou, Zhejiang, China.
出版信息
Front Cell Dev Biol. 2024 Oct 30;12:1515978. doi: 10.3389/fcell.2024.1515978. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Unlocking the potential of cell therapy: exploring cell types, induction methods, and culture techniques.
Front Cell Dev Biol. 2024 Oct 30;12:1515978. doi: 10.3389/fcell.2024.1515978. eCollection 2024.
2
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies.
Cytotherapy. 2022 Apr;24(4):405-412. doi: 10.1016/j.jcyt.2021.10.010. Epub 2022 Jan 14.
3
Explorations of CRISPR/Cas9 for improving the long-term efficacy of universal CAR-T cells in tumor immunotherapy.
Life Sci. 2023 Mar 1;316:121409. doi: 10.1016/j.lfs.2023.121409. Epub 2023 Jan 19.
4
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
Protein Cell. 2017 Sep;8(9):634-643. doi: 10.1007/s13238-017-0410-x. Epub 2017 Apr 22.
5
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
Hum Immunol. 2018 Dec;79(12):876-882. doi: 10.1016/j.humimm.2018.09.007. Epub 2018 Sep 24.
6
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing.
Mol Cancer. 2022 Mar 18;21(1):78. doi: 10.1186/s12943-022-01559-z.
7
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapy.
Cancer Med. 2019 Aug;8(9):4254-4264. doi: 10.1002/cam4.2257. Epub 2019 Jun 14.
8
CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.
Front Cell Dev Biol. 2021 May 20;9:674467. doi: 10.3389/fcell.2021.674467. eCollection 2021.
9
Combination of CRISPR/Cas9 System and CAR-T Cell Therapy: A New Era for Refractory and Relapsed Hematological Malignancies.
Curr Med Sci. 2021 Jun;41(3):420-430. doi: 10.1007/s11596-021-2391-5. Epub 2021 Jul 3.
10
The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Brief Funct Genomics. 2019 Mar 22;18(2):129-132. doi: 10.1093/bfgp/ely011.
引用本文的文献
1
Scale-down bioreactors-comparative analysis of configurations.
Bioprocess Biosyst Eng. 2025 Jun 5. doi: 10.1007/s00449-025-03182-w.
Zotero 插件